634 related articles for article (PubMed ID: 35457124)
21. Inflammatory myopathies.
Amato AA; Greenberg SA
Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1615-33. PubMed ID: 24305450
[TBL] [Abstract][Full Text] [Related]
22. [Idiopathic Inflammatory Myopathies].
Tomaras S; Kekow J; Feist E
Dtsch Med Wochenschr; 2020 Jul; 145(13):903-910. PubMed ID: 32615605
[TBL] [Abstract][Full Text] [Related]
23. Contribution of Complement, Microangiopathy and Inflammation in Idiopathic Inflammatory Myopathies.
Honda M; Shimizu F; Sato R; Nakamori M
J Neuromuscul Dis; 2024; 11(1):5-16. PubMed ID: 38143369
[TBL] [Abstract][Full Text] [Related]
24. Idiopathic inflammatory myopathies: a review.
Ashton C; Paramalingam S; Stevenson B; Brusch A; Needham M
Intern Med J; 2021 Jun; 51(6):845-852. PubMed ID: 34155760
[TBL] [Abstract][Full Text] [Related]
25. Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation.
De Lorenzo R; Monno A; Sciorati C; Lorenzetti I; Cavalli S; Bonomi F; Previtali SC; Rovere-Querini P
Clin Exp Rheumatol; 2022 Feb; 40(2):237-246. PubMed ID: 34796850
[TBL] [Abstract][Full Text] [Related]
26. Where are we moving in the classification of idiopathic inflammatory myopathies?
Tanboon J; Uruha A; Stenzel W; Nishino I
Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
Dourmishev LA
Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
[TBL] [Abstract][Full Text] [Related]
28. Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy.
Muñoz-Braceras S; Pinal-Fernandez I; Casal-Dominguez M; Pak K; Milisenda JC; Lu S; Gadina M; Naz F; Gutierrez-Cruz G; Dell'Orso S; Torres-Ruiz J; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Cells; 2023 Sep; 12(17):. PubMed ID: 37681930
[TBL] [Abstract][Full Text] [Related]
29. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
30. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
[TBL] [Abstract][Full Text] [Related]
31. Update on Myositis Therapy: From Today's Standards to Tomorrow's Possibilities.
Glaubitz S; Zeng R; Rakocevic G; Schmidt J
Curr Pharm Des; 2022; 28(11):863-880. PubMed ID: 34781868
[TBL] [Abstract][Full Text] [Related]
32. Immune Mediated Necrotizing Myopathy: Where do we Stand?
Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
[TBL] [Abstract][Full Text] [Related]
33. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
34. Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options.
Zeng R; Glaubitz S; Schmidt J
Neurotherapeutics; 2022 Apr; 19(3):911-921. PubMed ID: 35394612
[TBL] [Abstract][Full Text] [Related]
35. High-Dimensional Cytometry Dissects Immunological Fingerprints of Idiopathic Inflammatory Myopathies.
Nelke C; Pawlitzki M; Schroeter CB; Huntemann N; Räuber S; Dobelmann V; Preusse C; Roos A; Allenbach Y; Benveniste O; Wiendl H; Lundberg IE; Stenzel W; Meuth SG; Ruck T
Cells; 2022 Oct; 11(20):. PubMed ID: 36291195
[TBL] [Abstract][Full Text] [Related]
36. [Myositis: From classification to diagnosis].
Fer F; Allenbach Y; Benveniste O
Rev Med Interne; 2021 Jun; 42(6):392-400. PubMed ID: 33248855
[TBL] [Abstract][Full Text] [Related]
37. [Inflammatory myopathies: diagnosis and classifications].
Dimitri D
Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
[TBL] [Abstract][Full Text] [Related]
38. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
Lazarou IN; Guerne PA
J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies: Pathogenic or epiphenomenon.
Galindo-Feria AS; Wang G; Lundberg IE
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101767. PubMed ID: 35810122
[TBL] [Abstract][Full Text] [Related]
40. Utilization of myositis antibody-specific panel for diagnosis, treatment, and evaluation of disease progression.
Stark A; Hauptman H; Nguyen B; Mathew M; Aversano A; Mueller J
J Community Hosp Intern Med Perspect; 2020 Sep; 10(5):462-465. PubMed ID: 33235684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
